ENZON, Inc. - New Chairman Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ENZON, Inc. - New Chairman

ENZN 0.0400

0.0%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ed who wrote (15)	3/25/1997 8:06:00 PM
From: GC	of 96

To All, This board is DEAD. I don't understand the lack of interest for this company. With the new management team and the multitude of things going for Enzon now, you'd think this stock would start moving. It is absolutely a fantastic story but it doesn't seem to get enough coverage. That will change soon I believe as this company is headed for a great future. Insiders are buying and drugs are being developed. The company should be cash flow positive by the end of this year and next year could be big if royalties from Green Cross Corporation, a Japanese pharmaceutical company developing recombinant Human Serum Albumin(rHSA) using Enzon technology, start next year. HSA has a $400 million market in Japan. In 1999 or 2000 their potential blockbuster should get approval. Several other SCA licensed drugs are undergoing clinical trials presently, with milestone payments and royalties due if they advance to sales. The management team is tops and they say management management management. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next